ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000203.1|BE-7585A_1 # 1 # 150 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.620	BGC0000203.1|BE-7585A_1 	1	150	+	Loose	500	23.0978	OXA-662	29.41	3005877	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	CTGCAGAAGCACGGCTACCACCGGAAGGGCCTCCAGAAGGTCCGGGCGGCGAGCGAGATCGCGCCCCACATGGACATCGAGAACAACCGATCCAAAAGCTTCCAGGTCTTCCGCGACGGTCTGCGGCGCCTGGTGAAAGAAGGAAACTGA	LQKHGYHRKGLQKVRAASEIAPHMDIENNRSKSFQVFRDGLRRLVKEGN	MKTLQFGFIALITTFSSACTTISPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIRYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHAVQDLLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMHMKTGISASVREQLVKQSLTALGII	17.88	gnl|BL_ORD_ID|3912|hsp_num:0	4982			174	327	cloxacillin; oxacillin; cefalotin
BGC0000203.1|BE-7585A_2 # 150 # 3464 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AAGGA;rbs_spacer=5bp;gc_cont=0.698	BGC0000203.1|BE-7585A_2 	150	3464	+	Loose	350	46.595	vanO	25.91	3002913	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGCCGAAGAGGACGGACATCCAGCACGTGCTGGTGATCGGCTCCGGGCCGATCGTGATCGGGCAGGCCGCGGAGTTCGACTACTCCGGGACCCAGGCCTGCCGGGTGCTGCGCAGCGAAGGCTTGCGCGTTTCCCTGGTGAACTCGAACCCGGCCACCATCATGACCGACCCCGAGTTCGCCGACGCGACCTACATCGAGCCGGTGACGCCGGACTTCGTCGAGAAGGTCATCGCCGCCGAACGGCCCGACGCGATCCTCGCCACCCTCGGGGGGCAGACCGCGCTCAACTGCGCCGTCGCGCTGCACGAGCGCGGGGTGCTCGACAAGTACGGCGTCGAGCTGATCGGGGCCGACATCGACGCCATCCAGCGTGGTGAGGACCGGCAGAAGTTCAAGGACATCGTGCGCACCATCGGCGCCGAGGTCCCGCGCAGCCGGGTCTGCCACGACATGGCCGAGGTCCGGGACACCGTCAAGGAACTCGGCCTGCCGGTCGTCATCCGGCCGTCGTTCACCATGGGCGGGCTCGGGTCCGGCATGGCGCACACGCCCGAAGACCTCGAGCGGCTCGCCTCCACCGGGCTCACCGAATCCCCGGTCACCGAGGTGCTCATCGAGGAGAGCGTGCTCGGCTGGAAGGAGTACGAGCTCGAGCTGATGCGCGACAAGCACGACAACGTCGTGGTCGTCTGCTCGATCGAAAACGTCGACGCGATGGGCGTGCACACCGGCGACTCGGTCACCGTGGCGCCGACCATGACGCTCACCGACCGCGAGTACCAGGTGATGCGCGACGTCGGCATCGCCGTGCTGCGCGAGGTCGGCGTCGACACCGGTGGCTGCAACATCCAGTTCGCGATCAACCCCGAAGACGGCCGGATGGTCGTCATCGAGATGAACCCGCGGGTGTCGCGAAGCAGCGCCCTCGCGAGTAAAGCCACCGGCTTCCCGATCGCCAAGATCGCCGCGAAGCTCGCCATCGGCTACACCCTCGACGAGATCCAGAACGACATCACCGGCGAGACGCCGGCGGCGTTCGAGCCCACTTTGGACTACGTCGTCGTGAAGATCCCGCGGTTCGCCTTCGAGAAGTTCCCGGGCGCGGACCCGACGCTGACCACGACGATGAAGAGCGTCGGCGAGGCGATGTCGTTCGGGCGCAGCTTCCCCGAGGCGCTCGGCAAGGCGATGCGGTCGATCGAGACCAAGGCGACCGGCTTCTGGACGCTGCCCGACCCCGAAGGTGCCACCGTGGAGTCCACTTTGGACTCTCTGCGCACGCCGCACGAAGGCCGGCTGTACGAAGTGGAACGCGCGCTGCGGCTGGGCGCCAGCGTCCAGCAGGTGCACGAAGCGAGCGGCATCGACCCGTGGTTCGTCGACCAGATCGCCCTCATCGGCGAGGTCGGCGCCGAGGTGCGCGACGCACCCGTCCTCGACGGCGACCTGCTGCGCCGCGCCAAGCGCACCGGGCTGTCGGACCGCCAGATCGCCGCGCTGCGGCCGGAACTGGCCGGCGAGGACGGTGTCCGCGCGCTGCGGCACCGCCTCGGCGTGCGGCCGGTCTTCAAGACCGTCGACACCTGCGCGGCCGAGTTCGCCGCCAAGACGCCGTACCACTACTCGGCCTACGAGTCCGACCCCGACGCACCGTCCGAAGTGGCCGTGCAGAGCGACAAGCCGAAGGTGCTCATCCTCGGCTCGGGCCCGAACCGGATCGGCCAGGGCATCGAGTTCGACTACTCCTGCGTGCACGCGGCGATCGCGTTGCGGGAAGCCGGGTTCGAGGCCGTCATGGTCAACTGCAACCCGGAAACCGTGTCCACCGACTACGACACCTCGGACCGGCTGTACTTCGAGCCGCTGTCCTTCGAGGACGTCCTCGAGGTCGTGCACGCCGAGCAGGCGTCCGGCACGGTCGCCGGCGTCATCGTCCAGCTCGGCGGGCAGACCCCGCTGGGGCTGGCCAAGAAGCTCGCCGACGCCGGTGTCCCGGTGGTCGGGACGCCGCCCGAGGCCATCCACCTGGCCGAGGACCGCGGCGCGTTCGGCGAGGTGCTCACCGACGCCGGCCTGCCCGCGCCGCGCTACGGCACGGCGACGTCCTTCGAGGGCGCCAAGCGGATCGCCGACGAGATCGGCTACCCGGTGCTCGTCCGGCCGTCGTACGTCCTCGGCGGGCGCGGCATGGAAATCGTCTACGACGAGGAGACCCTGGCCGGCTACATCGGCCGCGCCACGGAGATCACCCCCGAGCACCCGGTGCTCGTCGACCGCTTCCTCGACGACGCCATCGAAATCGACGTCGACGCGCTGTTCGACGGCGAGGAGCTCTACCTCGGCGGCGTCATGGAGCACATCGAGGAAGCCGGGATCCACTCCGGTGACTCTTCGTGCGCGCTGCCGCCGATCACGCTCGGGCACACCGACCTGCAGGCCGTCCGCCGCTCCACCGAGGCGATCGCGCGGGGCGTCGGCGTCCGCGGGCTCCTGAACGTCCAGTACGCGCTCAAGGACGACGTCCTGTACGTCCTGGAGGCCAACCCGCGCGCGTCGCGGACGGTGCCGTTCGTGTCCAAGGCGACGGCGGTGCCGCTGGCGAAGGCGGCCGCGCTCGTCATGACCGGCTCGACGATCAAGGACCTGCGCCGCAGCGGGGTCCTGCCGGCCGAGGGCGACGGCGGGCAGATGCCCGCCGACTCGCCGGTCGCGGTCAAGGAAGCGGTCCTGCCCTTCCACCGCTTCCGCACCCCCGAGGGCCACGGCGTGGATTCCTTGCTGGGCCCGGAGATGAAATCCACCGGCGAGGTGATGGGCGTCGACGTCTCCTTCGGCAAGGCGTTCGCCAAGTCGCAGAGCGGCGCGTACGGCTCGCTGCCGACGTCCGGGCGCGTGTTCGTCTCGGTCGCCAACCGCGACAAGCGCTCGCTGGTGTTCCCGGTGAAGCGGCTGGCGGACCTCGGTTTCGAGATCCTCGCCACGTCCGGCACCGCGGAAGTGCTGCGGCGCAACGGGGTCGCGTGCACCGTAGTGCGCAAGCACTACGAGGGCTCGACCGAAGCCGAGCCGAACATCGTGGACGTCATCCTCGCGGGCGAAGTCGACATGGTGATCAACACCCCGTACGGCAACAGCGGTCCGCGCGTCGACGGCTACGAAATCCGCACCGCCGCGGTGTCGCGCGACATCCCGTGCGTGACGACCGTGCAGGGCGCCGCGGCGGCCGTGCACGGCATCGAGGCGCTGATCCGGGGCGACATCGGGGTCAAGTCGCTGCAGGAGCTGCAGGCGGCGCTGAAGGCGAAGTCGTGA	MPKRTDIQHVLVIGSGPIVIGQAAEFDYSGTQACRVLRSEGLRVSLVNSNPATIMTDPEFADATYIEPVTPDFVEKVIAAERPDAILATLGGQTALNCAVALHERGVLDKYGVELIGADIDAIQRGEDRQKFKDIVRTIGAEVPRSRVCHDMAEVRDTVKELGLPVVIRPSFTMGGLGSGMAHTPEDLERLASTGLTESPVTEVLIEESVLGWKEYELELMRDKHDNVVVVCSIENVDAMGVHTGDSVTVAPTMTLTDREYQVMRDVGIAVLREVGVDTGGCNIQFAINPEDGRMVVIEMNPRVSRSSALASKATGFPIAKIAAKLAIGYTLDEIQNDITGETPAAFEPTLDYVVVKIPRFAFEKFPGADPTLTTTMKSVGEAMSFGRSFPEALGKAMRSIETKATGFWTLPDPEGATVESTLDSLRTPHEGRLYEVERALRLGASVQQVHEASGIDPWFVDQIALIGEVGAEVRDAPVLDGDLLRRAKRTGLSDRQIAALRPELAGEDGVRALRHRLGVRPVFKTVDTCAAEFAAKTPYHYSAYESDPDAPSEVAVQSDKPKVLILGSGPNRIGQGIEFDYSCVHAAIALREAGFEAVMVNCNPETVSTDYDTSDRLYFEPLSFEDVLEVVHAEQASGTVAGVIVQLGGQTPLGLAKKLADAGVPVVGTPPEAIHLAEDRGAFGEVLTDAGLPAPRYGTATSFEGAKRIADEIGYPVLVRPSYVLGGRGMEIVYDEETLAGYIGRATEITPEHPVLVDRFLDDAIEIDVDALFDGEELYLGGVMEHIEEAGIHSGDSSCALPPITLGHTDLQAVRRSTEAIARGVGVRGLLNVQYALKDDVLYVLEANPRASRTVPFVSKATAVPLAKAAALVMTGSTIKDLRRSGVLPAEGDGGQMPADSPVAVKEAVLPFHRFRTPEGHGVDSLLGPEMKSTGEVMGVDVSFGKAFAKSQSGAYGSLPTSGRVFVSVANRDKRSLVFPVKRLADLGFEILATSGTAEVLRRNGVACTVVRKHYEGSTEAEPNIVDVILAGEVDMVINTPYGNSGPRVDGYEIRTAAVSRDIPCVTTVQGAAAAVHGIEALIRGDIGVKSLQELQAALKAKS	MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWENRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYVGCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFGVSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGFFRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGRVVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR	319.08	gnl|BL_ORD_ID|1607|hsp_num:0	1754			342	975	vancomycin
BGC0000203.1|BE-7585A_4 # 4417 # 4734 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGAGGA;rbs_spacer=4bp;gc_cont=0.682	BGC0000203.1|BE-7585A_4 	4417	4734	+	Loose	340	24.2534	sta	47.06	3004699	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	GTGGCACTTCCCCAGCTGACAGAGGAACAGCGCGCTGCGGCGCTGGAGAAGGCCGCCGCCGCTCGCAAGATCCGTGCTGAGCTGAAGGAGCGGCTGAAGCGGGGCGGTACCACTCTGGTCGACGTGCTGAAGCAGGCCGAGGAGAACGAAGTCCTCGGCAAGATGAAGGTTTCGGCTCTGCTCGAGGCCCTCCCGGGCGTCGGCAAGGTCCGCGCACAGCAGACCATGGAACGACTGGAGATCGCCCCCAGCCGTCGTCTCCGCGGCCTCGGCGACCGGCAGCGCAAGGCGCTGCTGGCCGAGTTCAGCGGCGAGTGA	MALPQLTEEQRAAALEKAAAARKIRAELKERLKRGGTTLVDVLKQAEENEVLGKMKVSALLEALPGVGKVRAQQTMERLEIAPSRRLRGLGDRQRKALLAEFSGE	MTTTHGSTYEFRSARPGDAEAIEGLDGSFTTSTVFEVDVTGDGFALREVPADPPLVKVFPDDGGSDGEDGAEGEDADSRTFVAVGADGDLAGFAAVSYSAWNQRLTIEDIEVAPGHRGKGIGRVLMRHAADFARERGAGHLWLEVTNVNAPAIHAYRRMGFAFCGLDSALYQGTASEGEHALYMSMPCP	55.56	gnl|BL_ORD_ID|2220|hsp_num:0	3397			315	366	streptothricin
BGC0000203.1|BE-7585A_5 # 4731 # 5384 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000203.1|BE-7585A_5 	4731	5384	+	Loose	750	27.335	patB	27.03	3000025	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAACGGCGCCGGTCGTGACTACCCGGTGAACCGGGGCGCCGACCGCGGCAGTGAGCCGGTGACGGGGGACCTCCCCCGGCACCGGCTCACCGTCGTATCGGGGCCTTCGGGGGTCGGGAAGTCGAGCGTGGTGGGCGAGCTGCGGAAGCTGGAGCCCGATCTCTACTTCAGCGTCTCGGTGACCACGCGCAAGCCCCGCCCCGGCGAAGTCGAGGGCGCGCACTACCACTTCGTCGACCGCGCCGAGTTCGACGCGATGGTCGCCGAAGGCAGGCTCCTGGAGTGGGCCGAGTTCACCGGCAACTGCTACGGCACCCCCCGCGAACCGGTCGAGAAGGCCCTCGCCGAGGGCCGCCCGGCGATCCTGGAGATCGAGCTTCAGGGCGCCCGGCAGGTCCGCGCGGCGATGCCGGAGGCCCGGCTGGTGATGCTGATGCCGCCGTCCTGGGAAGAACTGGTCGGCAGGCTCACCGGGCGCGGCACCGAAAACGAGGCCGCCGTGCAGGCCCGGCTGGCCGAAGCGGAGCGCGAACTGGCGGCCGCGGGGGAGTTCGACCACCGCGTTGTCAACGCCGACGTGCGGGAGGCCGCGGAGCACTTGCTAAACTTGATAACCGATCAGTCTTCCGAAGATGCGGAGCACCACGCGTGA	MNGAGRDYPVNRGADRGSEPVTGDLPRHRLTVVSGPSGVGKSSVVGELRKLEPDLYFSVSVTTRKPRPGEVEGAHYHFVDRAEFDAMVAEGRLLEWAEFTGNCYGTPREPVEKALAEGRPAILEIELQGARQVRAAMPEARLVMLMPPSWEELVGRLTGRGTENEAAVQARLAEAERELAAAGEFDHRVVNADVREAAEHLLNLITDQSSEDAEHHA	MKTVQFFWHYFKVYKFSFVVVILMIVLATFAQALFPVFSGQAVTQLANLVQAYQNGNPELVWQSLSGIMVNLGLLVLVLFISSVIYMCLMTRVIAESTNEMRKGLFGKLAQLTVSFFDRRQDGDILSHFTSDLDNILQAFNESLIQVMSNIVLYIGLILVMFSRNVTLALITIASTPLAFLMLIFIVKMARKYTNLQQKEVGKLNAYMDESISGQKAVIVQGIQEDMMAGFLEQNERVRKATFKGRMFSGILFPVMNGMSLINTAIVIFAGSAVLLNDKSIETSTALGLIVMFAQFSQQYYQPIIQVAASWGSLQLAFTGAERIQEMFDAEEEIRPEKAPTFTKLQESVEISHIVFSYLPDKPILKDVSISAPKGQMTAVVGPTGSGKTTIMNLINRFYDVDAGGIYFDGKDIRGYDLDSLRSKVGIVLQDSVLFSGTIRDNIRFGVPDASQEMVEVAAKATHIHDYIESLPDKYDTLIDDDQSIFSTGQKQLISIARTLMTDPEVLILDEATSNVDTVTESKIQHAMEVVVAGRTSFVIAHRLKTILNADQIIVLKDGEVIERGNHHELLKLGGFYSELYHNQFVFE	36.90	gnl|BL_ORD_ID|1911|hsp_num:0	2112			1083	1194	ciprofloxacin; norfloxacin
BGC0000203.1|BE-7585A_6 # 5381 # 5650 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.663	BGC0000203.1|BE-7585A_6 	5381	5650	+	Loose	750	23.8682	smeA	64.29	3003051	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCAGCCAGGTAGCCTTGACCGAAGAGCTCGAGGGCATCACCAACCCCCCGATCGACGACCTGCTCGAAAAGGTCAGCTCGAAGTACGCGCTGGTGATCTACTCGGCCAAGCGCGCCCGCCAGATCAACGACTACTACGCCCAGCTGGGCGAGGGTCTCCTCGAGTACGTCGGCCCGCTCGTCGAGCCGGGCCCGCGCGAGAAGCCGCTCTCGATCGCGCTGCGCGAGATCCACGGCGGCCTGCTCGAGCACACCGAGGGTGAGTAA	MTSQVALTEELEGITNPPIDDLLEKVSSKYALVIYSAKRARQINDYYAQLGEGLLEYVGPLVEPGPREKPLSIALREIHGGLLEHTEGE	MSLLRPLSRSPRPLLLPLLLALAACSADRTDAPAMPEVGVIIASAQPLALQQTLPGRAVPFEISEVRPQIGGLIRQRLFTEGQQVKAGQLLYQVDPAPYQAAFDTARGQLAQAEATVLSAQPKAERTRALVSMDAASKQDADDATSALKQAQANVIAARAALQAARINLDYTRVTAPIDGRIGTSSVTAGALVAAGQDTALTTIQRLDPVYLDVTQSSTQMLALRKRLDAGLVKAIDGKAQVKVLLEDGSTYAHEGTLEFVGSAVDPGTGNVKLRAVIPNPDGLLLPGMYLKAVLPMATDARALLVPQKAVVRNERGEPLLRLLDAKDHVVERRVSTGQVVGNQWQITSGLKAGERVIVSNGSAVSLGQQVKAVAPTTAQLAAMPAVDPNGNTDEKSH	22.36	gnl|BL_ORD_ID|1388|hsp_num:0	1507			762	804	
BGC0000203.1|BE-7585A_7 # 5643 # 6863 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.722	BGC0000203.1|BE-7585A_7 	5643	6863	+	Loose	1200	26.5646	LRA-13	22.56	3002484	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase; class D LRA beta-lactamase	GTGAGTAAACCCCGCGTCGTCCTGGGCGTGGGCGGCGGCATCGCCGCCTACAAGGCCTGTGAGGTGCTGCGCGGGCTGACCGAATCCGGTCACGACGTCCGCGTGGTCCCCACCGAAGCCGCGCTGAACTTCGTCGGCGCGGCGACCTTCGAGGCCCTCTCGGGGCACCCGGTGCACACCGGCGTGTTCACCGAGGTCCCCGAGGTGCAGCACGTCCGCGTCGGCAAGGAAGCCGACCTCGTCCTGGTCGTCCCGGCCACGGCGAACCTGCTCGCCAAGGCCGCGCACGGCCTCGCGGACGACCTGCTGACGAACACCCTGCTCACCGCCCGGTGCCCGGTCGCCTTCTTCCCGGCGATGCACACGGAGATGTGGGAGCACCCCGCGACCCGCGCCAACGTCGCCCTGCTGCGCTCGCGCGGCACGATCGTCACCGAGCCCGACGCGGGCCGGCTGACCGGCGTCGACACCGGCAAGGGCCGGCTGGCGAACCCGGCCGAGATCGTCGACCTCGCCAAGCTGCTGCTGGCCCGCCCCGACGCCCTCCCGCGCGACCTCGAAGGGGTCCGCGTCGTGGTGTCCGCGGGCGGCACGCGCGAGCCGCTCGACCCGGTCCGCTACCTGGGCAACCGCTCGTCGGGCAAGCAGGGCTACGCGCTGGCCCGCGTCGCCGCCCAGCGCGGCGCCGACGTCACCCTGGTCACCGCGCACACCGTCGCGCTGCCGGACCCGGCGGGCGCGACCGTGCAGCACGTGTCGACCGCCGAGGAGCTGCGGCAGGCGGTGCACGCCGCGTCCCACTCCGCGGACGTCGTCGTGATGGCCGCCGCGGTCGCCGACTTCCGGCCGGCGAACCGGGCCGACGTCAAGATCAAGAAGTCCGACGACCAGCCGGACCCGGTCATCACCCTGGACCGCAACGCGGACATCCTGGCCGAACTGGTGCAGAACCGGCGTCCCGGCCAGGTCGTCGTCGGGTTCGCCGCGGAAACCGGCGACGAGCACGGCAGCGTCCTCGACCACGCCCGTGCGAAGCTCAAGCGCAAGGGCGCCGACCTGCTGGTCGTCAACGCGGTCGGCGACGGCAAGGCGTTCGGCACCGAGGACAACTCGGGCTGGCTCCTAGGGGCAGATTCCACTGAAAAACCCCTACCTCTCGTGCAGAAAGCGGAACTGGCGTCCATGGTGTGGGACGCTGTTGTGAGCTTCATGAAGCGTTGA	MSKPRVVLGVGGGIAAYKACEVLRGLTESGHDVRVVPTEAALNFVGAATFEALSGHPVHTGVFTEVPEVQHVRVGKEADLVLVVPATANLLAKAAHGLADDLLTNTLLTARCPVAFFPAMHTEMWEHPATRANVALLRSRGTIVTEPDAGRLTGVDTGKGRLANPAEIVDLAKLLLARPDALPRDLEGVRVVVSAGGTREPLDPVRYLGNRSSGKQGYALARVAAQRGADVTLVTAHTVALPDPAGATVQHVSTAEELRQAVHAASHSADVVVMAAAVADFRPANRADVKIKKSDDQPDPVITLDRNADILAELVQNRRPGQVVVGFAAETGDEHGSVLDHARAKLKRKGADLLVVNAVGDGKAFGTEDNSGWLLGADSTEKPLPLVQKAELASMVWDAVVSFMKR	MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR	66.67	gnl|BL_ORD_ID|1764|hsp_num:0	1912			18	369	
BGC0000203.1|BE-7585A_8 # 6945 # 8159 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.708	BGC0000203.1|BE-7585A_8 	6945	8159	+	Loose	500	25.7942	cmrA	29.41	3002702	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACGGCCACCGTGACCGCGTCTAGCAGCAGATTGTTCACCTCGGAGTCGGTGACCGAAGGGCACCCCGACAAGATTTGCGACGCCATCAGCGACTCGATCCTCGACGGTCTCCTGTCGAAGGACCCGCGCAGCCGCGTCGCGGTCGAGACCCTGATCACCACCGGCCAGGTGCACGTGGCCGGCGAGGTGACGACCGAGGCCTACGCCGACATCCCCACGATCGTCCGCGACGTCATCCTGAAGATCGGCTACGACTCCTCCGCCAAGGGGTTCGACGGCAACTCCTGCGGCGTCAACGTCGCGATCGGCTCGCAGTCGCCCGACATCGCCCAGGGCGTCGACACCGCGTACGAGTCGCGGGTCGAGTCCGACGAGGACGAGATCAACCGCCAGGGCGCCGGCGACCAGGGCCTGATGTTCGGCTACGCCTGCTCGGACACCCCCGAGCTGATGCCGCTGCCGATCGCGCTGGCCCACCGCCTCTCCAAGCGCCTGACCGCGGTCCGCAAGGACGGCGTGCTGCCGTACCTGCGCCCGGACGGCAAGACCCAGGTGACCATCGAGTACGCCGGTGACCAGCCGGTCCGCCTCGACACGGTCGTCGTGTCCTCGCAGCACGCCGACGGCATCGACCTCGAGCGGATGCTCAGCGTCGACGTCAAGGAGCACGTGGTCGGCCCCGAGCTCGAAGGCCTGGGCATCGACACGGCGAGCGCGCGCCTGCTGGTCAACCCGACCGGCCGGTTCGTCATCGGCGGCCCGATGGGCGACGCCGGCCTGACCGGCCGCAAGATCATCGTCGACACCTACGGCGGCATGGCCCGCCACGGTGGTGGCGCGTTCTCCGGCAAGGACCCGTCCAAGGTCGACCGCTCCGCCGCGTACGCGATGCGCTGGGTGGCCAAGAACGTCGTCGCCGCCGGGCTGGCGTCGCGCACCGAGGTCCAGGTCGCGTACGCGATCGGCAAGGCGGCCCCGGTCGGCCTGTTCGTCGAGACGTTCGGGACCGAGACGGTCGACCCGTCGAAGATCCAGCAGGCCATCACCGAGGTCTTCGACCTCCGGCCGGCGGCGATCATCCGCGACCTCGACCTGCTGCGCCCGATCTACGCCCCGACCGCGGCGTACGGCCACTTCGGCCGTCCCGAGCTGGGCCTCCCCTGGGAGAGCACGGCCCGCGCCGAGGCGCTGAAGGCCGCCGCGGGCGCCTGA	MTATVTASSSRLFTSESVTEGHPDKICDAISDSILDGLLSKDPRSRVAVETLITTGQVHVAGEVTTEAYADIPTIVRDVILKIGYDSSAKGFDGNSCGVNVAIGSQSPDIAQGVDTAYESRVESDEDEINRQGAGDQGLMFGYACSDTPELMPLPIALAHRLSKRLTAVRKDGVLPYLRPDGKTQVTIEYAGDQPVRLDTVVVSSQHADGIDLERMLSVDVKEHVVGPELEGLGIDTASARLLVNPTGRFVIGGPMGDAGLTGRKIIVDTYGGMARHGGGAFSGKDPSKVDRSAAYAMRWVAKNVVAAGLASRTEVQVAYAIGKAAPVGLFVETFGTETVDPSKIQQAITEVFDLRPAAIIRDLDLLRPIYAPTAAYGHFGRPELGLPWESTARAEALKAAAGA	MPFAIYVLGLAVFAQGTSEFMLSGLIPDMARDLGVSVPAAGLLTSAFAVGMIIGAPLMAIASMRWPRRRALLTFLITFMLVHVIGALTSSFEVLLVTRIVGALANAGFLAVALGAAMAMVPADMKGRATSVLLGGVTIACVAGVPGGAFLGEIWGWRAAFWAVVVISAPAVVAIMFATPAEPPAESTPNAKRELSSLRSRKLQLMLVLGALINGATFCSFTYMAPTLTDISGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLAVGSAALLTGWIVFALTASHPAVTLVMLFVQGALSFAVGSTLISQVLYAADAAPTLGGSFATAAFNVGAALGPALGGLAIGMGLSYRAPLWTSAALVTLAIVIGAATLSLWRRPASVQETVPA	103.32	gnl|BL_ORD_ID|1599|hsp_num:0	1744			189	342	chloramphenicol
BGC0000203.1|BE-7585A_10 # 10689 # 10868 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=5bp;gc_cont=0.594	BGC0000203.1|BE-7585A_10 	10689	10868	+	Loose	900	21.9422	PmpM	38.89	3004077	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	GTGCTGGAAAACGATTGCTTCGACCGGCCGGGCCGGGTCACGCGGGGTCGGGTGATCGAAATTCGGATCGCGCATGATTTGCGCGCCGGGCTGACGAAATCCTTGGCGCGCAACGGATTTCACTGTCGGTTCGATGGGATTTCCTTCGACTTGACAGCAGATGTCCGCCTGTTAGGCTGA	MLENDCFDRPGRVTRGRVIEIRIAHDLRAGLTKSLARNGFHCRFDGISFDLTADVRLLG	MNSPALPLSRGLRIRAELKELLTLAAPIMIAQLATTAMGFVDAVMAGRASPHDLAAVALGNSIWIPMFLLMTGTLLATTAKVAQRHGAGDQPGTGPLVRQALWLALLIGPLSGAVLWWLSEPILGLMKVRPELIGPSLLYLKGIALGFPAAALYHVLRCYTNGLGRTRPSMVLGIGGLLLNIPINYALIYGHFGMPKMGGPGCGWATGSVMWFMFLGMLFWVNKASIYRASQLFSRWEWPDRATIGPLVAVGLPIGIAVFAESSIFSVIALLIGGLDENVVAGHQIALNFSALVFMIPYSLGMAVTVRVGHNLGAGLPRDARFAAGVGMAAALGYACVSASLMLLLREQIAAMYSPDPAVIAIAASLIVFSALFQFSDALQVTAAGALRGYQDTRVTMIMTLFAYWGIGLPVGYSLGLTDWFQEPTGPRGLWQGLVVGLTGAAIMLCIRLARSARRFIRQHERLQREDAEAASVLGR	12.37	gnl|BL_ORD_ID|2378|hsp_num:0	2734			903	957	neomycin; benzalkonium chloride; chlorhexidine
BGC0000203.1|BE-7585A_11 # 11012 # 11689 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGGGGG;rbs_spacer=6bp;gc_cont=0.674	BGC0000203.1|BE-7585A_11 	11012	11689	+	Loose	400	139.813	vanR gene in vanM cluster	36.21	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCACGTGCTGGTGGTGGAAGACGACGAAAAAGGTGCGGCCGTCCTGGTCGACGGACTGCGCCGCTCCGGGCACGAGGCCACCGGGGTCTCGAGCGGGGCCGAAGCGCTCGAAAAACATTGGGATGCCGATCTGATCCTGCTCGATCTGGGCATTGCGGACATCGACGGATTCGAGGTGTGCCGCCGGATCAGAAATGCCAGGGACGCGCCGATCATCGCGTTCACCGAACGCGGGACCGAAGCCGACCGGGTGCTCGGGCTCCGGGCCGGAGCCGACGATTGCCTGGACAAACCGTGCGGTTTCTGGGAACTGATGGCACGCATCGAAGCGGTCACCAGAAGAGTGCGCGGCCGGGCCGGTTCGGACGGGTCGCTGGTCGTGCGCGGCCCGCTGCGGATCGACGCGACCACGCGGCGGGTGCGCCTCGGCGGCGCGTCCATCGAAATGACGCGCAAGGAGTTCGACCTGCTGTACCGCCTGGCCAGCGAGCCGGGCGTGGTGTTCTCCCGGCGGCGGCTGATGGCCGAGATCTGGGGTGACCCGATGACGCACACGGCCGACACGAAGGTCAGCCGCACGATCGACACGCACGTCAGCGTGCTGCGCCGGAAGCTGGGCTCGAACCAGTGGATCCGCACCGTTCACGGTGTGGGGTTCTGCTTCACCGGAAACTGA	MHVLVVEDDEKGAAVLVDGLRRSGHEATGVSSGAEALEKHWDADLILLDLGIADIDGFEVCRRIRNARDAPIIAFTERGTEADRVLGLRAGADDCLDKPCGFWELMARIEAVTRRVRGRAGSDGSLVVRGPLRIDATTRRVRLGGASIEMTRKEFDLLYRLASEPGVVFSRRRLMAEIWGDPMTHTADTKVSRTIDTHVSVLRRKLGSNQWIRTVHGVGFCFTGN	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	96.98	gnl|BL_ORD_ID|4735|hsp_num:0	752			15	696	vancomycin; teicoplanin
BGC0000203.1|BE-7585A_12 # 11964 # 13427 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAGGA;rbs_spacer=3bp;gc_cont=0.766	BGC0000203.1|BE-7585A_12 	11964	13427	+	Loose	550	331.643	Nocardia farcinica rox	45.92	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGACGCGCCTGTCGTCATCGCCGGGGCCGGCCCCGCCGGTCTCATGCTGGCCGGCGAGCTGCGCCTGGCCGGGATCGGCGTGGTCGTGCTCGAACGGCTGCCCGCGCGCACCGGGGAATCACGCGGGCTCGGCTTCACCGCGCGGACCATGGAGGTCTTCGACCAGCGCGGCCTGCTCCGCCGCTTCGGTGAGGTCCAGACCAGCGACCAGGGGCACTTCGGTGGCATCCCGGTCGACTTCGGGCTGCTGGACGGCGCGCACCAGGCGGCGAAGACCATCCCGCAGTCGGCGACCGAAGCGGTGCTGGAGGCGTGGGCCGGCGAGCTCGGCGCCGACATCCGGCGCGGGCACGAGCTGACCGGCGTCCGCGACGACGGCGACGGCGTGGCGGTCACCGTGCGCGGCCCGGCCGGCGAGCACGTCCTGCGGGCCGGCTGGCTCGTGGGCTGCGACGGCGGCCGCAGCGCCGTGCGGAAGGCCGTCGGCTTCGACTTCCCCGGCACCGCCGCGACGCGCGAGATGTTCCTCGCCGACCTGCGCGGCGTCGAGCTGGAACCCCGCATGATCGGGGAAAGCCTGCCGGGCGGGATGGTGATGGTCGGGCCGCTGCCCGGCGGCGTCACCCGGATCATCGTCTGCGAACGGGACGCGCCACCGCGGCGGCGCACCGGGCCGCCGCCGTTCCACGAGGTCGCCGACGCGTGGAAGCGCATCACCGGCATCGACATCTCGGCCGCCGAACCGGTCTGGCTCAGCGCCTTCGGCGACGCGACCCGGCAGGTCACCGAATACCGGCGCGGCCGCGTCCTGCTCGCCGGCGACGCCGCGCACGTCCACCTCCCCGCGGGCGGGCAGGGCATGAACGCCGGCATCCAGGACGCGGTGAACCTCGGCTGGAAACTGGCCGCGGTCGTGCGCGGCACCGCGCGAGCGGACCTGCTGGACACCTACCACGGCGAACGGCACCCGGTCGGCGTCCGGCTGCTGATGAACACCCGGGCCCAGGGCCTGCTGTTCCTCAACGGCGCGGAAATGCAGCCGCTGCGCGACGTCCTCGCCGAGCTGACCGGCTACCCCGACGTCGCCAGGCACCTCGCCGCGATGGTCAGCGGCCTGGAGATCGCCTACGACGTCGGCGGGGGGAGCCACCCGTGGCTCGGGCGCCGGCTGCCGCGGCTGGAGCTCGACCGCGGCGGCCGCCCCTCGTCCACGGCGGAGCTGCTGCGCCCCGCGCGCGGCCTGCTGCTCGACTTCGCCGGCAACGCGGCGTTGCGCGACCGCGCGGCGCCCTGGGCCGGCCGGATCGACGTCGTCACCGCCCGCCCGGCCGCCGGGCGGGTCCCCGGCGCCACCACCGCGGTCCTGGTCCGCCCGGACGGCCACGTGGCCTGGGCGGCCCCGGGCACGCACGCCGACCTGCCGATGGCGCTCGAGCGCTGGTTCGGGCCGGCGCCCCGCTAG	MDAPVVIAGAGPAGLMLAGELRLAGIGVVVLERLPARTGESRGLGFTARTMEVFDQRGLLRRFGEVQTSDQGHFGGIPVDFGLLDGAHQAAKTIPQSATEAVLEAWAGELGADIRRGHELTGVRDDGDGVAVTVRGPAGEHVLRAGWLVGCDGGRSAVRKAVGFDFPGTAATREMFLADLRGVELEPRMIGESLPGGMVMVGPLPGGVTRIIVCERDAPPRRRTGPPPFHEVADAWKRITGIDISAAEPVWLSAFGDATRQVTEYRRGRVLLAGDAAHVHLPAGGQGMNAGIQDAVNLGWKLAAVVRGTARADLLDTYHGERHPVGVRLLMNTRAQGLLFLNGAEMQPLRDVLAELTGYPDVARHLAAMVSGLEIAYDVGGGSHPWLGRRLPRLELDRGGRPSSTAELLRPARGLLLDFAGNAALRDRAAPWAGRIDVVTARPAAGRVPGATTAVLVRPDGHVAWAAPGTHADLPMALERWFGPAPR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	102.96	gnl|BL_ORD_ID|4834|hsp_num:0	5821			9	1416	rifampin
BGC0000203.1|BE-7585A_13 # 13451 # 13777 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AAGGA;rbs_spacer=8bp;gc_cont=0.700	BGC0000203.1|BE-7585A_13 	13451	13777	+	Loose	275	23.0978	AAC(6')-Iid	27.45	3002589	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCACAGCACCCTGATCGTGGCCCGCATGCGCCCGGACGCGGACCAGGCGGTCGCCGAGCTGTTCGGCGAGTTCGACGCCGGCGAGATGCCCCACCGGATGGGGACCCGGCGGCGCCAGCTGTTCAGCTACCGGGGGCTCTACTTCCACCTGCAGGACTTCGACGCCGAGGACGGCGGCGAACGGATCGAGACGGCGAAGGGCGATCCCCGGTTCGTCCGGATCAGCGAGGACCTCAAGCCGCACATCGCCGCCTACGACCCGGACACCTGGCGCTCGCCCAAGGACGCCATGGCGGAGTGCTTCTACCGCTGGAGCGCCGAGTGA	MHSTLIVARMRPDADQAVAELFGEFDAGEMPHRMGTRRRQLFSYRGLYFHLQDFDAEDGGERIETAKGDPRFVRISEDLKPHIAAYDPDTWRSPKDAMAECFYRWSAE	MIISEFDRENIVLRDQLADLLRLTWPDEYGTEPMKEVEQLMAPERIAVSAIEGEELVGFVGAIPQYGKTGWELHPLVVASTHRKQQIGTRLVSYLEKEVASYGGLVIYLGTDDVEGQTNLVETDLFEDTFAKLQEIKNINHHPYTFYEKLGYQIIGVIPDANGWNQPDIWLAKRVAKREPTE	59.34	gnl|BL_ORD_ID|1691|hsp_num:0	1831			252	405	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000203.1|BE-7585A_14 # 13774 # 15042 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.735	BGC0000203.1|BE-7585A_14 	13774	15042	+	Loose	750	186.808	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	33.24	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGACGGCCCGGCGGGTGGTCGTCACCGGCGTCGGGGTCACCGCACCCGGCGGCGTCGGCGCCAAGGACTTCTGGAGCCTGCTCTCCGAAGGGCGGACCGCGACGCGGCGGATCAGCTTCTTCGACCCGTCGCCGTTCCGGTCCCAGGTGGCCGCGGAGATCGACTTCGACGCGGAGCTGCTCGGGCTGGGCCCGCAGGAGATCCGGCGGATGGACCGCGCGGCGCAGCTCGCGGTGGTCACCGCGCGGGAAGCGGCGGCCGACAGCGGGCTGGAGTTCGCCGGCCTGCCCCCGCACCGGGTCGGCGTGACGGTCGGCAGCGCGGTCGGCGCGACCACCGGGCTGGACCAGGAGTACCGGACCGTGTCCGACGGCGGCCGGCTGGAGCTCGTCGACCACGAGTACGCCGTACCGCACCTGTACAACTACTTCGTCCCCAGCTCCTTCGCCGCGGAAGTGGCCTGGACGGTCGGGGCGGGCGGCCCGGTCTCGGTGGTGTCCACCGGCTGCACGTCCGGGCTCGACGCCGTCGGCCACGCGACCGAGCTGATCCGCGAAGGCAGCGCCGACGTCGTGCTGGCCGGCGCCACCGACGCGCCGATCAGCCCGATCACGGTCGCCTGCTTCGACGCGATCAAGGCGACCACCCCGCGCAACGACGACCCGGAGCACGCCTCACGGCCGTTCGACGGCACCCGCAACGGGTTCGTGCTCGGTGAGGGCTCCGCGATGTTCGTGCTGGAGGAGCTGGAAAGCGCTCGCCGCCGCGGCGCCCAGGTGTACGCCGAGGTGGCCGGGTTCGCTTCGCGGTGCAACGCCTACCACATGACCGGCCTGCGCCCGGACGGCCGCGAAATGGCCGAAGCGATCCGGGTGGCGCTCGGCGAAGCCCGGCTGGCCCCCGACGCCGTCGACTACGTCAACGCGCACGGCTCGGGCACCCGCCAGAACGACCGGCACGAAACGGCCGCGTTCAAGCTGAGCCTGGGGGAGCACGCGCACCGGGTCCCGATCAGCTCCGTGAAGTCGATGGTCGGCCACTCGCTCGGCGCGATCGGCTCGATCGAGGTCGCCGCCTCGGTGCTGGCGATGCGCGAGAACGTCGTGCCGCCGACGGCGAACCTGCACATCGCCGACCCCGAGTGCGACCTCGACTACGTCCCGGTGACCGCGCGCGAGCACCGGACCGACACCGTGCTCTCCGTCGGCAGCGGCTTCGGCGGCTTCCAGAGCGCGATCGTGCTGACCCGGCCCGGGGCGGCGGCGTGA	MTARRVVVTGVGVTAPGGVGAKDFWSLLSEGRTATRRISFFDPSPFRSQVAAEIDFDAELLGLGPQEIRRMDRAAQLAVVTAREAAADSGLEFAGLPPHRVGVTVGSAVGATTGLDQEYRTVSDGGRLELVDHEYAVPHLYNYFVPSSFAAEVAWTVGAGGPVSVVSTGCTSGLDAVGHATELIREGSADVVLAGATDAPISPITVACFDAIKATTPRNDDPEHASRPFDGTRNGFVLGEGSAMFVLEELESARRRGAQVYAEVAGFASRCNAYHMTGLRPDGREMAEAIRVALGEARLAPDAVDYVNAHGSGTRQNDRHETAAFKLSLGEHAHRVPISSVKSMVGHSLGAIGSIEVAASVLAMRENVVPPTANLHIADPECDLDYVPVTAREHRTDTVLSVGSGFGGFQSAIVLTRPGAAA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|1968|hsp_num:0	1943			213	1245	isoniazid
BGC0000203.1|BE-7585A_15 # 15039 # 16310 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=7bp;gc_cont=0.770	BGC0000203.1|BE-7585A_15 	15039	16310	+	Loose	250	26.9498	vanG	30.14	3002909	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	GTGACCGCGGTCGAGGCGCGGCCGGCGCCGGGCGCGGCGGAGCACGCGGGCACCGGGCCGGTCGTGGTGACCGGGATCGGCGTCACGGCCCCGACCGGGCTGGGCGCGGGACGGCACTGGAGCGCCACCCGCGCCGGCGAGTCCGCGATCCGCCGGATCACCCGCTTCGACCCCGCCCGCTACCCGGCGCGGCTGGCCGGGCAGGTCACCGGGTTCGACCCGGCCGCGCACCTGCCGGGCCGGCTGCTGCCGCAGACCGACCTGATGACCCAGCTCGCGCTGGTGGCCGCCGACGAGGCGCTGGCCGACGCCGGCGTGAACCCGGACGAGCTGCCGTCGTTCAGCATGGGCGTGGTCACCGCGAGCTCGTCCGGCGGCTTCGAGTTCGGGCAGAACGAACTGCGCAACCTGTGGTCCCGCGGTGGCAAGTACGTCAGCGCCTACCAGTCGTTCGCGTGGTTCTACGCCGTCAACAGCGGGCAGATCTCCATCCGGCACGGGATGCGCGGGCCCAGCGGCGTGGTGGTGAGCGACCAGGCGGGCGGCCTCGACGCCGTCGCGCAGGCCCGCCGCCAGATCCGCAAGGGCACCGGCCTGGTGGTCTCCGGCGGGATGGACGCGTCGATCTGCCCGTGGGGCTGGGCGGCGCAGCTGGCCGCGGGGACGCTGAGCACGAGCGACGACCCGCGGCGGGCCTACCTGCCCTTCGACACCGCGGCGGCCGGGCACGTACCCGGTGAGGGCGGGGCGCTGCTGATCCTGGAGCCGCTCGCGGCCGCCGAGGCCCGCGGAGCCGAGGTCTACGGCGAGATCGCCGGGCACGCGGCGACCTTCGACCCGCCGCCCGGCAGCGGCGGGGAACCCGGGCTGCGGCGGGCGATCGAGCTCGCGCTGGCCGACGCCGGCACCACCGCGGCCGAGGTCGACGTCGTGTTCGCCGACGCGGCCGCCGTTCCCGCGCTCGACCGCGCCGAGGCGGCGGCGATCCGCGCGGTGTTCGGCCCGCACGGCGTCCCGGTGACCGCGCCGAAGACGCTGACCGGGCGGCTCTGCTCCGGGGCGGCCGCGCTCGACCTCGCCACGGCGCTGCTTTCCCTGCGCCACGGCGTCCTCCCGCCGGCCACCGGGGTCCGCCCGGCCGCCGGGCTCGAACTCGATCTGGTCACCGAGGCCCGCCCGCGCCCGCTGCGGTCGGCGCTGGTCCTCGCCCGGGGCAACGGGTTCAACTCGGCGATGCTCGTCCGCACCGTCCACAGTGGAAAGAAAGGCTAG	MTAVEARPAPGAAEHAGTGPVVVTGIGVTAPTGLGAGRHWSATRAGESAIRRITRFDPARYPARLAGQVTGFDPAAHLPGRLLPQTDLMTQLALVAADEALADAGVNPDELPSFSMGVVTASSSGGFEFGQNELRNLWSRGGKYVSAYQSFAWFYAVNSGQISIRHGMRGPSGVVVSDQAGGLDAVAQARRQIRKGTGLVVSGGMDASICPWGWAAQLAAGTLSTSDDPRRAYLPFDTAAAGHVPGEGGALLILEPLAAAEARGAEVYGEIAGHAATFDPPPGSGGEPGLRRAIELALADAGTTAAEVDVVFADAAAVPALDRAEAAAIRAVFGPHGVPVTAPKTLTGRLCSGAAALDLATALLSLRHGVLPPATGVRPAAGLELDLVTEARPRPLRSALVLARGNGFNSAMLVRTVHSGKKG	MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE	121.20	gnl|BL_ORD_ID|1069|hsp_num:0	1157			255	447	vancomycin
BGC0000203.1|BE-7585A_16 # 16313 # 16573 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AAAGG;rbs_spacer=6bp;gc_cont=0.713	BGC0000203.1|BE-7585A_16 	16313	16573	+	Loose	1900	26.9498	MuxB	25.0	3004074	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCGACACGGGATTCACCCTCGACGACCTGATGCGGATCCTGCGCGAGGGCTCGGGGGAGACCGAAGAACCGGCCGGCGATCCCGCCGGCGTCGAGTTCGCCGACCTGGGCTACGACTCGCTGGCGCTGCTGGAAACCGCCGGCCGGATCGAGCGCGAGTACGGCCTGACCCTCGACGAATCCGCACTGGCGGAGGCCACGACGCCGCGGGCGCTGGTCGAGCTGGTGAACGAGCACCTGGCCCGGGTCCGCGCCTGA	MSDTGFTLDDLMRILREGSGETEEPAGDPAGVEFADLGYDSLALLETAGRIEREYGLTLDESALAEATTPRALVELVNEHLARVRA	MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR	8.25	gnl|BL_ORD_ID|2364|hsp_num:0	2718			1185	1473	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000203.1|BE-7585A_17 # 16605 # 17390 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.718	BGC0000203.1|BE-7585A_17 	16605	17390	+	Loose	700	25.0238	PDC-397	42.42	3006766	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGACCGACCAGGAAGGCCGCACCGCGGTCGTCACCGGCGCCACGAGCGGGATCGGGCTCGCCGTGAGCAAGCTGCTGGCCCGCCGGGGCCTGCGCGTTTTCCTCGGCGCACGCACCGCCGAGAACGTCGCCACCACCGTGAAGGAGCTGCGCGACGCCGGCTTCGAAGCCGACGGGGCCGCGTGCGACGTGCGGTCCGGCGAGGACGTGACCGCGTTCGTGCGCGCCGCCGTCGACCGGTACGGCCCGGTCGGCGTGCTCGTCAACAACGCCGGCCGCCCGGGCGGCGGTGTCACCGCGGAGATCGCCGACGAGCTGTGGCTCGACGTCATCGAAACCAACCTCACCAGCGTGTTCCGGGTGACCCGCGAGGTCCTCACCACCGGCGGCATGGTGGCGGCCGGCCACGGCCGGATCGTCAACATCGCTTCCACCGCGGGAAAACAAGGGGTCGTGCTGGGCGCGCCGTACTCGGCGTCCAAGCACGGGGTCGTCGGGTTCACCAAGGCGCTCGGCAACGAGCTGGCCCCGGCCGGCATCACCGTCAACGCGGTCTGCCCCGGCTACGTCGAAACCCCGATGGCCGAACGGGTCCGGCAGGGTTACGCGGCCGCGTACGGGACGTCCGAGGACGAGGTGCTGAAGAAGTTCCAGGCCAAGATCCCGCTCGGCCGCTACTCGACGCCGGACGAGGTCGCGGGCCTCGTCGGCTACCTGGTGACCGACACCGCGGGCTCGATCACCGCGCAGGCGCTCAACGTCTGCGGCGGGCTCGGCAACTTCTGA	MTDQEGRTAVVTGATSGIGLAVSKLLARRGLRVFLGARTAENVATTVKELRDAGFEADGAACDVRSGEDVTAFVRAAVDRYGPVGVLVNNAGRPGGGVTAEIADELWLDVIETNLTSVFRVTREVLTTGGMVAAGHGRIVNIASTAGKQGVVLGAPYSASKHGVVGFTKALGNELAPAGITVNAVCPGYVETPMAERVRQGYAAAYGTSEDEVLKKFQAKIPLGRYSTPDEVAGLVGYLVTDTAGSITAQALNVCGGLGNF	MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPIAERVKIAYAILSGLEQQAKVPLKR	65.74	gnl|BL_ORD_ID|4456|hsp_num:0	5526			1113	1191	
BGC0000203.1|BE-7585A_18 # 17418 # 18347 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAGGA;rbs_spacer=5bp;gc_cont=0.712	BGC0000203.1|BE-7585A_18 	17418	18347	+	Loose	600	28.1054	Rm3	27.71	3003894	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	Rm3 family beta-lactamase	ATGCGCGAAGCGGAACACGACATCCTCGTCGACGCGCCGGCGGACGAGGTCTACCGGCTCGTCGCGGAAGTGGCGAACTGGCCGCGGATCTTCCCGCCGACGGTCTTCGTCGACCACGTCGAGCGGGGCGAAGGCACCGAGCGGATCCGGATCTGGGCGACCGCCAACGGCGAGCCCAAGAACTGGACCTCGCGCCGCGAACTCGACCCGGCGGCCCGGCGGATTTCCTTCCACCAGGAGGTTTCCACGCCGCCCGTCGCCGAGATGAGCGGCACGTGGATCGTCGAACCGGTGTCGGCGGCCACGGCGAAGGTGCGGCTCCTGCACGCCTACCGCGCGGTCGGCGACGACCCGGGCGGCCTGGCGTGGATCGACCGGGCGGTCGACACGAACAGCCGGTCGGAACTGGCCGCGCTCAAGCACAACGTCGAACTGGTGACCAACCCCGAGCTGACGTTCTCGTTCACCGACACCGTCCGGATCGACGCCCCGGCCAAGGACGTGTACGACTTCGTCGACCAGGCCGCGCTGTGGGCCGAGCGGCTGCCGCACGTCTCTTCGGTCGACCTGCGCGAGCCGAGCCCCGGCCTGCAGGTGCTGCGGATGGACACCCGCGCGAAGGACGGTTCGGTGCACACCACCGAGTCGGTCCGGGTGTGCTTCCCGCACCACCGGATCGTCTACAAGCAGACCACGCTGCCCGCGCTGATGACGCTGCACACCGGCCGCTGGGACTTCGCCGAGGAGCCCGGCGGCGGCACGACGGCGTCGTCGGAGCACACCGTCGTGCTCAACACCGCGAACATCGCGAAGGTGCTCGGGGCCGGCGCCGGGGTCGCCGAGGCCCGCGAGTTCGTCCGGACCGCGCTGAGCACCAACAGCCGGGCGACGCTCGGCTTCGCGAAGGACCACGCGGAAGCGCGGCCGTGA	MREAEHDILVDAPADEVYRLVAEVANWPRIFPPTVFVDHVERGEGTERIRIWATANGEPKNWTSRRELDPAARRISFHQEVSTPPVAEMSGTWIVEPVSAATAKVRLLHAYRAVGDDPGGLAWIDRAVDTNSRSELAALKHNVELVTNPELTFSFTDTVRIDAPAKDVYDFVDQAALWAERLPHVSSVDLREPSPGLQVLRMDTRAKDGSVHTTESVRVCFPHHRIVYKQTTLPALMTLHTGRWDFAEEPGGGTTASSEHTVVLNTANIAKVLGAGAGVAEAREFVRTALSTNSRATLGFAKDHAEARP	MSLTPPRALVLALLLASPGTQAQTPAPATPPTPGCEVCATWNADQAPFRLFGNTYYVGMKGLSSVLVTSPQGHVLIDGGLPESAPKIIANIGALGFRIEDVKLILNSHGHIDHAGGLAELQRRSNALVAASPSAALDLASGEVGPDDPQYHALPKYPPVKDMRLARDGGQFNVGPVYLTAHATPGHTPGGLSWTWQSCDGPRCLNMVYADSINAVSRPGFKFSASSEYPNALADLRHSFETLEKLPCDVLISAHPEASQLWQRLEASATGGSDAFVDPQACRAYVAAARTLLDSRLDQEKQQ	102.32	gnl|BL_ORD_ID|4702|hsp_num:0	2375			447	669	
BGC0000203.1|BE-7585A_19 # 18344 # 20302 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=GGAAG;rbs_spacer=7bp;gc_cont=0.760	BGC0000203.1|BE-7585A_19 	18344	20302	+	Loose	600	206.068	Streptomyces venezuelae rox	37.92	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGACCCGCCTCGAGGCCGCCGACGTGCTCGTCGTCGGCGCCGGCCCGGCCGGTTTGCTGCTGGCGCACGACCTCAGCGCCGCCGGCGTCGCCGTGACCGTGCTGGAGCAGCGGACCGCGCCGCACACCGAGTCCCGCGCGTCGACGCTGCACGCCCGCACGATGGAGCTGTTCGCCGAACGCGGGCTGCTCGACGAGCTCGGCCCGCCGCCGCGCGGCGGGGCCGGTCACTTCGGCGGGCTCGGGCTCGACCTGACCGAGGCCGATCCGGCACACCCCTACGCGGGGCAGTGGAAAGCGCCGCAGACCGAGGTCGAAGCCGTGCTCGCCCGGCGGGCAGTGGCGCGCGGCGCGGACCTGCGCCGCGGGCACCGGGTCACCGCGCTGACCGAGCACGGGACCCACGTCGAGGTGACCGCGACCGGACCGGCCGGCCCGGCCCGGTGGCGGGCCGCCTTCGTCGCCGGCTGCGACGGCGAGGACAGCACCGTGCGCCGGCTGGCCGGCATCGGCTTCCCGGGCCACGACGCGAATCGGGAGCTGCTGCGGGCCGACGTCCGCGGGATCGACGTACCGGACCGGCGCTTCGAACGGCGCCCCGCCGGGCTCGCGATCGCCTCACGCGGGCCGGACGGGACGACCCGGCTCATGGTCCACGAATACGGCCGCGCCCCGCGCACTTCGCCGGGGGAGCCCGGGTTCGCCGAGTTCGCCGAGGTGTGGCGCCGCGTCACCGGCGAGGACGTCTCGCACGGCGAAGCCGTGTGGGTCAACGCCTTCGGGGACGTCCGGCGGCAGGCGGAGCGGTACCGCGCGGGCCGGATCGTGCTGGCCGGCGACGCGGCCCACGCGCAGCTCCCGGTCGGCGGCCAGGCGATCAACCTCGGCCTCCAGGACGCCGCGGAGCTCGCCCCGCGGCTGGCGGCCCAGTTCACCGGCGGGCCCGACGAGGCGCTGCTGGCGGGTTACCACGACGTCCGGCACGCGGTCGGGCGGCGCGCGCTCGCCGGCATCGAAGCCCAGGCGAACCTGCTGCTCGGCGGCCCGGAGGTCGAGGCGCTGCGCGAAGTGGTCGGGGAGCTGCTCGACCTCGGCCCGGTGCGCCGGCACCTCGCCGCGGCGATCAGCTCGCTCGACACCCCACGCCCGGCCGCGCGCCCCGGCGCCGGCCCCACCACCCCCAGGAGGACGGAAATGGCTCAGCTGAGCGGAAAGACCGCGCTGGTCACCGGGTCGAGCCGCGGCATCGGCCGCGCGACCGCCGAGCGGCTCGCCCGCGCCGGCGCGCTCGTCGCCGTGCACTACGCGGAAAACGAGGACGCGGCCGCCGAGGTCGTGGCCACCATCGAGGGCGACGGCGGACGGGCGTTCGCGGTGCGCGCCGACCTGGCCGCACCCGGCGGCGTCCACGAGCTGTTCCTCGCCCTCGAACTCGGGCTCAAGGAGCGCACCGGGAGCACCGACCTCGACATCCTGGTCAACAACGCCGGCGTGATGGGCGGGGTGGCCCCGGAGGACATCACGCCCGAGCAGTTCGACCGGCTCTACGCGGTCAACGCCAAGGCGCCGTTCTTCCTCGTCCAGCGCGCCCTGCCGAACCTGCCCGACGGCGGCCGGATCGTGAACATCTCCTCGGGCCTGACCCGGTTCGCGAACCCGCAGGAGGTCGCGTACGCGATGACCAAGGGCGCGGTCAACCAGCTCACCCTGCACTTCGCCAAGCACCTCGGCCCGCGCGGGATCACCGTGAACAGCGTCGGGCCGGGCATCACCGACAACGGCTCGCCGGTCTTCCGCAACGCCGAAGTCGTCGCGCAGATGGCGTCGCTCTCGGCGTTCGGCCGGGTCGGGGAGACCGACGACGTCGCCGCGGTCGTCGAGTTCCTCGCCGGCCCCGGCGCCCGCTGGATCACCGGGTCCTACGTGGACGCCAGCGGCGGTACCCTGCTGGGCGGCTGA	MTRLEAADVLVVGAGPAGLLLAHDLSAAGVAVTVLEQRTAPHTESRASTLHARTMELFAERGLLDELGPPPRGGAGHFGGLGLDLTEADPAHPYAGQWKAPQTEVEAVLARRAVARGADLRRGHRVTALTEHGTHVEVTATGPAGPARWRAAFVAGCDGEDSTVRRLAGIGFPGHDANRELLRADVRGIDVPDRRFERRPAGLAIASRGPDGTTRLMVHEYGRAPRTSPGEPGFAEFAEVWRRVTGEDVSHGEAVWVNAFGDVRRQAERYRAGRIVLAGDAAHAQLPVGGQAINLGLQDAAELAPRLAAQFTGGPDEALLAGYHDVRHAVGRRALAGIEAQANLLLGGPEVEALREVVGELLDLGPVRRHLAAAISSLDTPRPAARPGAGPTTPRRTEMAQLSGKTALVTGSSRGIGRATAERLARAGALVAVHYAENEDAAAEVVATIEGDGGRAFAVRADLAAPGGVHELFLALELGLKERTGSTDLDILVNNAGVMGGVAPEDITPEQFDRLYAVNAKAPFFLVQRALPNLPDGGRIVNISSGLTRFANPQEVAYAMTKGAVNQLTLHFAKHLGPRGITVNSVGPGITDNGSPVFRNAEVVAQMASLSAFGRVGETDDVAAVVEFLAGPGARWITGSYVDASGGTLLGG	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	136.97	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	1125	rifampin; rifaximin; rifapentine
BGC0000203.1|BE-7585A_20 # 20308 # 21501 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=3bp;gc_cont=0.795	BGC0000203.1|BE-7585A_20 	20308	21501	+	Loose	1000	79.337	efpA	33.14	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGCGCAGACGGCAGGTCCGGTCCGCGCGGCCCCGCGGCCGCTGGTCTTCGTGCTCGCCGGGACGATGCTGCTCGACGCGCTCGAGGTGTCGGTGCTCGTGCCCGTGCTCCCGGCGCTGGCCGGGGCGTTCGGCGCCGGGCCGGGGCAGGCGCAGTGGCTGCTGACCGCGTTCGCCGCCGGGTTCGGTGCGGTGCTGCCCGCGGGCCCGTGGCTCGCGGCCCGGTTCGGCACGCGGCGGGTCTACCTGGCGGCGTTGCTCGCCTTCGCGGCCGCGTCCGTGCTCGCCGGCGTGACCGGGGACTTCGCGGTGCTCGTGGCGGCCCGGCTGGTCAAGGGCGCGTGCGCCGCGCTCACCGCGCCCGGCGGGCTGGCCGTGCTCACCGCCGCGGTCCCCGAGGGCGACCGGCAGCGGCGGGCGGTGGCGCTGTACGCGGCGTTCGGCGCGGCGGGCTTCACCACGGGCCTGCTGGTGTCGGGTGCGCTCGCCGGCGCCGGACTGCGGTGGGTGCTGCTGTTCCCGGCGCCGGTCGCGCTGGTCCTCGCCGGGCTCGCCGCCACGGTGGTGCCCCCGGACGCGCCGCGGGCGCCGGTCGCGGCGTTCCCGCGGGGACTGGCGCGCAACGGCCCGTTCGCGCGGTCGGCGTTCGGCGCGGCGGCGCTCAACGGCACGTACCTGACGACCCTGCTGGTCACGACCCACGCGCTGCACGAACGCGGCTGGAGCCCGCTCGCCGTCGCCGCCGGCTGCCTGCCCGCGTGCCTGCCGGTCGCGCTGACCTCGCCGGTCACCGCGCGGCTGGTCGCGGCGATCGGCACCGCCCGGCTGATCGCCGCCGGCGCGGTGGCGGCCGCGGCGGGCTACGCCTGGCAGCTGCTGCCGCTGCCGGGGGACGGCTACCCGCGGCTGGCACCGACGCTGGTGCTGGCCGGTCTCGGGTTCGTCTTCGCCTTCGGCGCGCTCAACGTCCAGGCGGTGGCCGCGCTGCCGGCCGCGGCCCGGGCCAGGGCGGTCCCGGTCTACCAGAGCTGCGTGCAGTTCGGCGCGGTGGCCGTGGTGCTCGCGGGCGTGGCGGTGGCCGGCCTGGACGGTCCGGTGTGGACGGTCGTCACGGCGGTGGGGGGCGCGGGCGCGGCCGTCGCGCTCGCCGGGTGGCGGCGCGCGTCCGCGGAGTCTCGAGGAGGAAGCAGATGA	MAQTAGPVRAAPRPLVFVLAGTMLLDALEVSVLVPVLPALAGAFGAGPGQAQWLLTAFAAGFGAVLPAGPWLAARFGTRRVYLAALLAFAAASVLAGVTGDFAVLVAARLVKGACAALTAPGGLAVLTAAVPEGDRQRRAVALYAAFGAAGFTTGLLVSGALAGAGLRWVLLFPAPVALVLAGLAATVVPPDAPRAPVAAFPRGLARNGPFARSAFGAAALNGTYLTTLLVTTHALHERGWSPLAVAAGCLPACLPVALTSPVTARLVAAIGTARLIAAGAVAAAAGYAWQLLPLPGDGYPRLAPTLVLAGLGFVFAFGALNVQAVAALPAAARARAVPVYQSCVQFGAVAVVLAGVAVAGLDGPVWTVVTAVGGAGAAVALAGWRRASAESRGGSR	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	74.91	gnl|BL_ORD_ID|2188|hsp_num:0	2427			162	678	rifampin; isoniazid
BGC0000203.1|BE-7585A_21 # 21498 # 22598 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGAGGA;rbs_spacer=5bp;gc_cont=0.779	BGC0000203.1|BE-7585A_21 	21498	22598	+	Loose	1080	25.409	rosB	44.44	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCCTGAACACGCTCGACCACCCCGGCGCACCGGCGCGCCGGCACGACCGGTGCCTGCTCACGGCCCGGGAACGGATCTCCCTGCTGCTGGACCCTGGCTCGTTCACCGAGCTCGACCGCGGCGACGGCGTGCTCACCGGGCGCGGCGAGGTCGGGGGCCGCCCGGTGCACCTGTGGGCGCACGACCTGCGCTTCGCCGGTGGCGCGCTGGGGGAGGCGTCCGCCGCGGGGATCCAGCGGCTGCTGGACACCGCGCTGGCCGAAGGCACCCCCGTCGTGGCGCTCGACGACTGCGCCGGGGTGCGGGAGGACGTCGCCGCGCCGGACGGCTACGGCGGCACGCTGCGCCGGGCGGCCGCCCTGGCGGGCACCGTCCCGCAGATCACCGTCCTGCTCGGGCCCTGCCCGGGCGGCACGTCCTACGGCGCGGCACTGGCCGACTTCGTCTTCGCCGTCCGCGGCGCCGCGGCCCCGGCCACGGCGCAGTTCGTGCACGACGACGAGCCGACGTGCCTGGAGGACGTCCGGCGGCTGCTGACCCTGCTGCCGCCCAACCGGAACGAACCGCCCCGCACCGAGCCGTCCGAAGACCCGCCGGAACGCCTGGTGCGCCACCGGTCCGCCCTCGACGTCGGCGACCTCATCGCGGAGGTCGTGGACGACGGCGACTGCGTGACCATCGGGACCGGGCCGGGCACCCGGTGCGCGCTGGCCCGGATCGGCGGCCACGCGGTCGGCCTGGTGGCGGCGTGCGACCGCGCGGCGGGCGCCGGCGACGCCGCGCGGTTCGTCGGGTTCTGCGACACCTTCGGCATCCCCCTCGTCACGGTCGCGGACGTGCCGCCGGTCCGGCCGCACCCGGCGCTGCTGGCGGCGTACTGCGCGGCGACCACGCCCCGCATCTCGCTGCTGCTGCGACCGGCGGAAGCAGGCACCGGCCTGACGCTGGACTCCCGCCCGCTCGGCGCCGACGTCTGCCTGGCCTGGCGGCACGACGGACCGCGCCCGGCGGCCGACGAAGTGATCCAGCCCGCCCAGACCCGGCGGGTGCTGGTGCGGTGGCTCGCGGTGCTGCGCGCGCGGGCGGTGCCGCGGTGA	MSLNTLDHPGAPARRHDRCLLTARERISLLLDPGSFTELDRGDGVLTGRGEVGGRPVHLWAHDLRFAGGALGEASAAGIQRLLDTALAEGTPVVALDDCAGVREDVAAPDGYGGTLRRAAALAGTVPQITVLLGPCPGGTSYGAALADFVFAVRGAAAPATAQFVHDDEPTCLEDVRRLLTLLPPNRNEPPRTEPSEDPPERLVRHRSALDVGDLIAEVVDDGDCVTIGTGPGTRCALARIGGHAVGLVAACDRAAGAGDAARFVGFCDTFGIPLVTVADVPPVRPHPALLAAYCAATTPRISLLLRPAEAGTGLTLDSRPLGADVCLAWRHDGPRPAADEVIQPAQTRRVLVRWLAVLRARAVPR	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	65.01	gnl|BL_ORD_ID|466|hsp_num:0	507			1086	1167	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0000203.1|BE-7585A_22 # 22634 # 23512 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=AAAGG;rbs_spacer=7bp;gc_cont=0.739	BGC0000203.1|BE-7585A_22 	22634	23512	+	Loose	750	27.7202	tet(E)	24.85	3000173	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTCCGTGAAACCCCAGACCGTCCTGGTCGTCGGGCCCACCGGCAACGTCGGGCCGCACGCGCTGGCCCAGCTCCTCGAAGCCGGGGTGGCGGCCCGCGCGCTGGTGCCGCCCGGTGACCCGGCCGTGGCCCGGATCCCCGACGGCACCGAGGTCTTCGAAGGCGACCTGGCGGACCCCGAAAGCCTGGTGCCCGCGCTCGACGGCGTCACCGGCGTGTTCCTCATGTGGCCGTTCTTCACCCTCGACGTCAGCACCGCGCCCGCCGTGCTGGAGGTGATCAGCCGGTACACCGGGCGGGTCGTCTTCGTCTCCTCGATCGGTGTCCACATCGGACTGGAGCCGGTGGACAACAACTGCCACGCCTACCTCGAGCAGCAGATCGAGAAGGCCGGGCTGACGTGGACCTTCCTGCAGACCACCGGGTTCGCCTGCAACGCGCTCGGCTGGGCCGGCCAGCTCGATGGCGGCGACGTCGTGCGGTTCCCCTACGGCGGCGCCGTCCGGACGCCGGTCCACGAAGCCGACCTGGCCGCCGTCGGGGTCCGCGCGCTCACCGAGGACGGCCATGAGAACCGCCGCTACGTCGTGACCGGGCCCGAACCGCTCTCGCAGGCCGAACAGCTGCGGATCATCGGGGCGGCGGCCGGGCGCGAGCTCGCGTGGGCCGAGGTCGCCCACGACGCCGCGCGGCAGGCGATGGTCGGGGCCGGCTGGCCGCCCGCCTACGCCGACGGCGCGCTCGAGTACTTCGCGACCCTGGTCGAGGCGCCGGAGACGCGCACGGACACCGTCGCCGAGGTGCTCGGCAGGCCCGCCCGGACGTTCCGCGACTGGGCCGAAGAGCACGCGGACCGCTTCCGGCGCGGTGCGGCGTGA	MSVKPQTVLVVGPTGNVGPHALAQLLEAGVAARALVPPGDPAVARIPDGTEVFEGDLADPESLVPALDGVTGVFLMWPFFTLDVSTAPAVLEVISRYTGRVVFVSSIGVHIGLEPVDNNCHAYLEQQIEKAGLTWTFLQTTGFACNALGWAGQLDGGDVVRFPYGGAVRTPVHEADLAAVGVRALTEDGHENRRYVVTGPEPLSQAEQLRIIGAAAGRELAWAEVAHDAARQAMVGAGWPPAYADGALEYFATLVEAPETRTDTVAEVLGRPARTFRDWAEEHADRFRRGAA	MNRTVMMALVIIFLDAMGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPLLGRWSDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPEESRTHWFGMMGACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHNANQVSDELKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDGVMVGVSLAVFGLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVITQSWMVWPVLLLLACGGITLPALQGIISVRVGQVAQGQLQGVLTSLTHLTAVIGPLVFAFLYSATRETWNGWVWIIGCGLYVVALIILRFFHPGRVIHPINKSDVQQRI	72.10	gnl|BL_ORD_ID|147|hsp_num:0	142			771	1203	tetracycline
BGC0000203.1|BE-7585A_23 # 23509 # 24156 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.761	BGC0000203.1|BE-7585A_23 	23509	24156	+	Loose	450	25.409	HMB-1	40.0	3004092	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	HMB beta-lactamase	GTGACGACCGGCGACGAGGGGTTCGCCGGGTTCTGGGTGCTGTCGGCGGCGGACGCCGCGGCCGCGCGGCTCCTCTCCGCACAGCTCGACGACGAAATGCTGAGCCTGCGCGACGCGGCCGGGTTCCGGTCGGCGCGGCTGCACCTCGGCGTCGACGGGCGGACCGTGCTGCTCCGCCACGGCTGGCGCGGCGCCGCCGACCACGCGGCCTTCCGCGACGGGCCCTTCGCCCAGCGGCTGCGCGGGGTGGCCGGCCGGGCCGGCGTGCGCGCCCCGCGCTGCTACGGCGGCGAGCTCGTCGCCCGCATCGAAGGCCCGGACGCCGGTGCCGCGCCCGGGGTCGTCGTGCTGGCCGTCCGGCACGTCGGCGGCCGCCGCAGCGCCCTCGCGCTCACCGAGCTGCTGGAGCGCAGCGGGGACTGGAAGCGGGAGTTCCCGGGGTTCATCTCCGCGGACGCCGCGATCGGCCCCGACCACACCACGTTCGTCAACTATCCACAGTGGACCGATGTCGCCGCGTTCGACGCCTACATGGCGGATCCGCGCAACGCCGCGGGCCAGCCGGGGATCGCCCGGCTCGAAGCGGCCGAGCCCGTCATCGTGCGCTGCTCGGTCGTCGCCGAGGTGATCGCCGTAGAAAGGAGCTGA	MTTGDEGFAGFWVLSAADAAAARLLSAQLDDEMLSLRDAAGFRSARLHLGVDGRTVLLRHGWRGAADHAAFRDGPFAQRLRGVAGRAGVRAPRCYGGELVARIEGPDAGAAPGVVVLAVRHVGGRRSALALTELLERSGDWKREFPGFISADAAIGPDHTTFVNYPQWTDVAAFDAYMADPRNAAGQPGIARLEAAEPVIVRCSVVAEVIAVERS	MKIHLWISLGLLLLTNIVLAEEPLPELEVKKIDEGVYLHTSYENYPSWGLVASHGLVFVDGKDAYIIDTPATVKDTEVLVQWINDQGFKPKASISTHFHDDSTIGIAYLNSKSIPTYASEQTNELLNKEVAAQATHSFKKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFVKPEGLGNLSHAVVSEWPASAEKLINRYSDAKIVVPGHGTMGDASLLEKTKQRALEAVAKKK	89.21	gnl|BL_ORD_ID|4714|hsp_num:0	2753			114	204	
BGC0000203.1|BE-7585A_24 # 24158 # 25378 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AAAGG;rbs_spacer=7bp;gc_cont=0.748	BGC0000203.1|BE-7585A_24 	24158	25378	+	Loose	500	28.1054	AAC(3)-IVb	27.63	3005061	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGACCACCCCCGCCGAAGCACCCCCGGCCGGGCTGTTCACCGCCGGCTACTACCAGGACCCGTACCCGACGCTCGCCCGGCTGCGCGAGCACGACCCCGTGCACGAGTTCCGCTTCCCGGTCGGGGACGTGCGCATGTGGCTGGTCACGCGCTACGACGACGTGCGCGCCCTGCTCGCCGACCCGCGCTTCTCCTCCGAGGGCGGCACGTGGGGCAATTCCGAGTTCCGCGAGGCCGGCCTGGTCAGCGGCGCGGGCAGCGTCCTCGAACGCGCGGTCACCGTGGTCGACCCGCCCGCGCACACGCGGCTGCGCCGGCTCGCGATGAGCGCGTTCACCACCCGCCGCGTCGAGCGGTGGCGGGACGAGCTCACCGGGCTGGTGGACCGGACCCTGGACCGCTGCGCCGCGCTCGGCACGTTCGACGTCATGGACGACTTCGCCGGCGTCGTCTCCTCGGAGATGCTCGGCGCCATCCTCGGCCTGCGGATCGAGCGCCACCGCGACCTGGTGGACGCGCTGACCCAGGCGTTCCCGTCGGACCCGGCGCTGATGGACCGGGTGCCCGCCGGGTTCGCGCGGATCTGCGAGTACGCCGAGGAACTCGTCGCCGAGAAGCGCCGCACGCCCGCCGACGACCTGACGTCCGCGCTGGTCGAGGCGTCCGAAGACGGCGACCGCCTCGACGAGCGCGAGCTGGTCGCGATGGTGGCGGCGATGATCATGGCGGGCAGCGACACCGTCCGCGCGTTCCTCGGCAACGCGGTGCTCGCGCTGCTGGACCACCCGGACCAGCGGGCGGCGCTGACCGGCGGCGCGGACACCACGGCCGCGGTGGAAGAACTGCTGCGCTACGAAGGCGCGCTGACCACCGCGCTGTTCCGGGTGACCACCGAAGACGTCGACTTCGCCGGCACCCGCCTGCCCGCCGGCTCGCCGGTGATCACCGGGCTGCTCGCGGCGAACCGCGACCCGCGGCGGTTCCCCGACCCCGGACGGCTCGACCTGGCCCGGACCGGGCCGCGGCACGTCGGCTTCGGGCACGGCCTGCACAACTGCCTCGGCGCCGCGCTCGCCCGGCTGGAGATCGGGCTGTCGGTGACGGCGCTGTTCCGCCGGTTCCCCGGGCTGCGGCTCGCGACCGGGCGCGCGGACGTGCGCTACATCGAGAACTGGGCGATGCGGCGGCTGACCGCGCTCCCGGTGGACGCGGCGCGATGA	MTTPAEAPPAGLFTAGYYQDPYPTLARLREHDPVHEFRFPVGDVRMWLVTRYDDVRALLADPRFSSEGGTWGNSEFREAGLVSGAGSVLERAVTVVDPPAHTRLRRLAMSAFTTRRVERWRDELTGLVDRTLDRCAALGTFDVMDDFAGVVSSEMLGAILGLRIERHRDLVDALTQAFPSDPALMDRVPAGFARICEYAEELVAEKRRTPADDLTSALVEASEDGDRLDERELVAMVAAMIMAGSDTVRAFLGNAVLALLDHPDQRAALTGGADTTAAVEELLRYEGALTTALFRVTTEDVDFAGTRLPAGSPVITGLLAANRDPRRFPDPGRLDLARTGPRHVGFGHGLHNCLGAALARLEIGLSVTALFRRFPGLRLATGRADVRYIENWAMRRLTALPVDAAR	MVTQLRALGVPPGAVLLVHASFRSIRPVQGGPQGLIEALREAAGPAGTLVMPSWGDDDDAPFDPAATPAAADLGAVADAFWRLPDVVRSHHPFAFAAAGPQAHRITADPLPLPPHIPASPVGRVHELDGQVLLLGVGHDANTTIHLAELMAGVPYGVPHHCTVLRDGKPARIDYLENDHCCQRFDLVDGWLKEKGLQREGPVGNAGARLMRARDIVDVVRQQLARDPLVFLHPPQVGCEECDAARRSVSTK	161.75	gnl|BL_ORD_ID|2786|hsp_num:0	3801			531	753	tobramycin; gentamicin A; gentamicin
BGC0000203.1|BE-7585A_26 # 25593 # 26354 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AAGGGA;rbs_spacer=7bp;gc_cont=0.743	BGC0000203.1|BE-7585A_26 	25593	26354	+	Loose	450	30.8018	SSA	27.62	3007442	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	SSA beta-lactamase	ATGACCCAGGAGACCGAGCAGGCCGCCGACACCGAGCAGGTGATCGGCAGGCTGTGGGAACGCAACTACGACCCGGGGACCCGCGGGATGATCACCGGGCTCGGCATCCGCCCGGACTGGCGCTGCCTCGACCTCGGGGCCGGCCTCGGGTCGATGTCGCGCTGGCTGGCCGGGCAGGTCCCGCGGGGCTCGGTGCTCGCGCTCGACCGCGACACCACTGCCCTGGCCGGTGCCGCGGCGGACAACCTGACCGTGCGGCAGGCCGATCTGGCCGGAGCCGACTTCCCGGACGGCTCGTTCGACCTCGTGCTGGCCCGGGCGGTGCTGTCGTACCTGCCGGACCCGGAGGCGGTGCTCGACCGCGTGCACCGCTGGCTCGCGCCGGGCGGGTACCTCGTCGCCGAGGACTTCTACTTCATGCCGAGCGACGACTGCGCGACCCCGCTGGGCCGCCGGGTCGTCGAGGGCTACGCGAAGGCCGCCGCGGGCGCGGGCCTGGACTGGCGGCTCGCCCGCCGGCTGCCGTCGCTGCTCGCGCGCACCGGCTTCGAAGCCGTGGAGCAGACCGTCCGGCCGCTCGGGCCGGGGCAGGGTGAGGAGGAGAACGAGCTGATGCGGGCGCGGATGAACCTGCAGGGCGCGCCCCTGGTGGAAAACGGCCTGGTCTCCGCCGAAGACGTCGCCGAGTTCGTGGCGACGCTCGACCGGCCCGAGGTCCGGGACGTCACCACGCTGCTGTTTTCGGTGCGGGGGCGGCGATGA	MTQETEQAADTEQVIGRLWERNYDPGTRGMITGLGIRPDWRCLDLGAGLGSMSRWLAGQVPRGSVLALDRDTTALAGAAADNLTVRQADLAGADFPDGSFDLVLARAVLSYLPDPEAVLDRVHRWLAPGGYLVAEDFYFMPSDDCATPLGRRVVEGYAKAAAGAGLDWRLARRLPSLLARTGFEAVEQTVRPLGPGQGEEENELMRARMNLQGAPLVENGLVSAEDVAEFVATLDRPEVRDVTTLLFSVRGRR	MKRIFPAYILLTAFLLACSSNATTQNANQSNKPAAAQEAKADDKQNRELQKQIEQIASAARGRVGVHAVVLETGESVSLDEQGRFPMQSVYKFPIGMAVLAQVDAGKLKLDERVRVEKSEYVREGMHSPLRDKNPNEAEVSVRELLRLAVSESDGTASDVLFRLAGGSEAITRYLSDLKVTEIIVADTEKEIGQDWDTQYRNWASPKGAVMLLRAFHEGRGLSAESRALLLKLMTDTPTGPKRLKGLLPKGTVVAHKTGTSGANASGISAATNDIGIVTLPNGRHLAIAVFVSDSPADLTTREGVIAKVAKAAWDQWGK	79.31	gnl|BL_ORD_ID|4942|hsp_num:0	5934			555	849	cefoxitin; ceftazidime; amoxicillin; ampicillin
BGC0000203.1|BE-7585A_27 # 26351 # 27634 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=5bp;gc_cont=0.743	BGC0000203.1|BE-7585A_27 	26351	27634	+	Loose	700	47.7506	oleI	23.52	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAAGGTCCTCTTCTGCGCTCCTTCGGCGTTCGCGCACCTCAACCCGCTGGTGCCGCTGGCGGGCGCGCTGCAGGGCGCCGGCCACGAAGTCCGGGTGGCGACCCACCCGGAGATGACCGGCGCCGTGCGCGCGCTCGGCCTGACCGCGGTCGCGGCGGGGGAGTGGGACTTCCCCAAGGCCAACGCGCACGAGAGCGACGCGCTGTACGAGCGGGTGCTGGAGCTGATCGGCGACGAGGGCCGCGACCGCGCGCCCGGGCGGCCGCCGTCGAAGATGGTGCTGCGCGGGTTCCGCCGCTACTACGACCCGGAACCGCCGGGGGCGCGCGGGAACCTGCTCGCCGACGACCTGGTGGCGTTCGCCCTGCGGTGGCGCCCGGACCTGGTCGTCTGGGACTCGATCTCGTTCCCCGCCGCGATCGCGGCGCGGGTCTCCGGCGCCGCGCACGCCCGGGTGCTGTGGTCGGTGGACGACGTCGCGTGGCTGCGCGCCGTGCTCAACCGCGTCACCGCCCGCCCCGGCGCCCCGGCCGACCCGATGCTCGCGCACATGCGCCCGATGCTGGAGCGCTTCGGCGTCGAGTTCGGCGAAGACCTCCTGCTGGGCCAGTTCACCCTCGACGCCTACCCCGGCGTGCGGTTGCGCACGCCGGCGCCGGAGCTGCGGTACGTCCCGCTGCGGCCGGTGCCCTACACCGGCACGATGACCGTGCCGGACTGGCTGGACGACCCGGGCGGGCGCCCGCGGGTGGCGGTGTCGCTCGGGGCGGGCATCCGGAGCTTCTTCCCCGGCGGTACCAGCAAAGTCGCGGCCGAAGAGCTCTTCGAGGTCACCAGCGGGCTGGACGTCGAGGTCGTCGCGACGCTGAACGAGGCGCAGCTGGCGTCCGTCGGGCACGTGCCGGACCACGTCCGCGTCGTCGACTACCTGCCGCTGAACCTGCTGCTGCCTACCTGCGCGGCGATCATCCACCACGGCGGGGGCGGGACGTTCGCGGCCGCCGTCGCGCACCGGGTGCCGCAGCTGGTCTGGAAGGAACGCAGCGTCTACTACGACGACATCGCCCGGCTCGTCGAAACGAGCGGGGCCGGCCTGGTCGTCGACGACGAGCCGTTCGCCGCGGACGTGGTGCGCAAGCAGCTCACCCGGATCATGACCGAGCCGTCGTTCGCCGCCGGTGCGGCCGAACTGCGGCGGGACGCGCTGGCCGTGCCCGCGCCCACCGAAGTCGTTCCCGTGCTGGAACGGCTGACCGCCGAGCACCGCGGGGTGACCCGGTGA	MKVLFCAPSAFAHLNPLVPLAGALQGAGHEVRVATHPEMTGAVRALGLTAVAAGEWDFPKANAHESDALYERVLELIGDEGRDRAPGRPPSKMVLRGFRRYYDPEPPGARGNLLADDLVAFALRWRPDLVVWDSISFPAAIAARVSGAAHARVLWSVDDVAWLRAVLNRVTARPGAPADPMLAHMRPMLERFGVEFGEDLLLGQFTLDAYPGVRLRTPAPELRYVPLRPVPYTGTMTVPDWLDDPGGRPRVAVSLGAGIRSFFPGGTSKVAAEELFEVTSGLDVEVVATLNEAQLASVGHVPDHVRVVDYLPLNLLLPTCAAIIHHGGGGTFAAAVAHRVPQLVWKERSVYYDDIARLVETSGAGLVVDDEPFAADVVRKQLTRIMTEPSFAAGAAELRRDALAVPAPTEVVPVLERLTAEHRGVTR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	100.71	gnl|BL_ORD_ID|1684|hsp_num:0	1824			72	1266	oleandomycin
BGC0000203.1|BE-7585A_29 # 28611 # 29591 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=10bp;gc_cont=0.749	BGC0000203.1|BE-7585A_29 	28611	29591	+	Loose	1200	44.669	arnA	24.9	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCGGATCCTGGTCACCGGGGGAGCCGGGTTCATCGGCTCCGCCTACGTCCGCGGCCTGCTCGCCGGTGCCTACCCGGGCACGGACGGCGCGCGGGTCACCGTGCTCGACAACCTCGGCTACGCCGGCCGCCGCGACAACCTCCCGGCCGCGCACCCGCGGCTGGAGTTCGCCGAGGGCGACGTCCGGGACACCGCGCTGCTGGCCGCGCTCGTGCCCGGGCACGACCTGGTGGCGCACTTCGCCGCGGAGTCGCATGTGGACAGATCGCTGGCCGCGGCGGGCGACTTCCTGCGCACCAACGTGGAGGGCACCGGCGCGGTGCTGCAGGCGTGCGCCGACGCCCGCGTGGCCCGGGTCGTGCACGTGTCCACCGACGAGGTGTACGGCTCCATCGACGACGGCGCCTGGACCGAGGACTCGCCGCTGCTGCCGAATTCGCCGTACGCGGCGTCCAAGGCGGCGTCGGACCTGGTGGCGCGCGCGTACTGGCGCACCCACGGCCTCGACGTCTCGATCACGCGGTGCTGCAACAACTACGGGCCCCGCCAGCACCCCGAGAAGGTCATCCCGCTGTTCGTCACCAACCTGCTGCGGGACCGGCCCGTACCGCTCTACGGCGACGGGCGCAACGTGCGCGAATGGCTGCACGTCGACGACCACTGCCGCGCCGTGCACGCCGTGCTCACCGGCGGCCGCGCCGGCGCGGTGTACCACGTGGGCGGCGGGACCGGGCTGAGCAACCTGGAGCTCACCCGGCGGCTGCTCGAACTGTGCGGGGCCGGCGAGCGGCTGGTGCGCCGCGTGCCCGACCGCAAGGGGCACGACCGGCGCTACGCGCTGGACGACAGCCGCATCCGCACCGAGCTGGGCTGGGCCCCGCGCGTCCCGTTCGACACCGGGCTGGCCGCCACGGTCGCCTGGTACCGCGAAAACCCCGGCTGGTGGGCCGCTTCCGCGAGCCGCGCCGCCGCGCTGTGA	MRILVTGGAGFIGSAYVRGLLAGAYPGTDGARVTVLDNLGYAGRRDNLPAAHPRLEFAEGDVRDTALLAALVPGHDLVAHFAAESHVDRSLAAAGDFLRTNVEGTGAVLQACADARVARVVHVSTDEVYGSIDDGAWTEDSPLLPNSPYAASKAASDLVARAYWRTHGLDVSITRCCNNYGPRQHPEKVIPLFVTNLLRDRPVPLYGDGRNVREWLHVDDHCRAVHAVLTGGRAGAVYHVGGGTGLSNLELTRRLLELCGAGERLVRRVPDRKGHDRRYALDDSRIRTELGWAPRVPFDTGLAATVAWYRENPGWWAASASRAAAL	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.24	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1701	polymyxin B
BGC0000203.1|BE-7585A_33 # 33133 # 33777 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.757	BGC0000203.1|BE-7585A_33 	33133	33777	-	Loose	400	67.0106	MexL	31.71	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACAGCACCGAAGCGGCGGCGCGCCGCCCCCAGCGCTCCAGCGACAAGCGCCGCGCGATCCTCGACGGCGCCCGGGTCACCTTCGCCCGCGAGGGCTACAGCCGGGCGAGCATCGACGCGATCGCCGCCGCGGCGGACGTCTCCACGCGCACCCTGTACAACCACTTCGGCGACAAGGCGCGGCTGTTCCAGGAGGTCATCCAGACCAGCGCGACCGAGGTCGCCGAGGCCCAGCTCGCCCTGCTCGAGAGCCACTTCGGCGCCGTCACCGACGTCGAGGCGGCGCTCACCGCGTTCGCCGTCGCCTGGGCCCGGCCGAACCCGGAGTTCGCCGACCACTTCGCGCTCGTGCAGCAGATCCGGGCCGAGGCCGGGCACCTCCCGCCCGCGGTGCTGGCGGCCTGGCAGCAGGCCGGCCCGCACCGCGTCCAGGCGGAGCTCGCGGCGCGGCTGCGGCAGCTGGCCGAGCGCGGCCTGCTGCGCGTGGAGGACCCCGAGCGCGCCGCGTTCCACCTGTCGCTGCTCGCGGCGGCGGAGGTGGACAGCCGCAGCTACCACGGCGCGATCCCCGTCCCCGCCGCCGAAATCGCCGAGCTCGCCACCGCGGGCGTCCGGGTGTTCCTGCACGGCTACCTCCCCTGA	MNSTEAAARRPQRSSDKRRAILDGARVTFAREGYSRASIDAIAAAADVSTRTLYNHFGDKARLFQEVIQTSATEVAEAQLALLESHFGAVTDVEAALTAFAVAWARPNPEFADHFALVQQIRAEAGHLPPAVLAAWQQAGPHRVQAELAARLRQLAERGLLRVEDPERAAFHLSLLAAAEVDSRSYHGAIPVPAAEIAELATAGVRVFLHGYLP	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	100.94	gnl|BL_ORD_ID|4690|hsp_num:0	2219			27	624	erythromycin; tetracycline; triclosan
BGC0000203.1|BE-7585A_34 # 33880 # 34491 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=AAGGA;rbs_spacer=6bp;gc_cont=0.721	BGC0000203.1|BE-7585A_34 	33880	34491	+	Loose	400	26.5646	vanR gene in vanO cluster	30.56	3002930	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGACCCGGATCGCCGTCATCACCGGCAGCACCCGGCCGCGCCGCCGCGCGGCCCTGGTCGCCGCCTGGGTGCTCGAGGTCGCCGAACGGCACGCCGGCTCGGGCGACGTCAGCTTCGAAATCGTCGACCTGGCCGACTTCGACCTGCCGCTGCTCGACGAGCCGGTACCGGCGGCGATCGGCGACTACGCGAACGAGCACACGCGGCGCTGGGCGCGCGTCATCGACGGGTTCGACGGTTTCGTCTTCGTCACCCCCGAGTACAACCACTCGTACCCGGCCGCGCTGAAGAACGCGATCGACTACCTCTTCGCCGAGTGGGGCGACAAGGCGGCCGGGTTCGTCAGCTACGGCCTGCACGGCGGCATCCGCGCCGTCGAGCACCTGCGGGCCGCGGTGTCCGAGGTCAAGCTCGCGGACGTGCGCTCGTGCGTGGCGTTGTCGCTCTTCGCCGACTTCAAGATCACCGACATGACGCAGCCGGGCGAGTTCGCGCCCGGCGACCACCAGGAGCCGACGCTCACCCGGATGATCGACGAGGTCGTGGCCTGGTCGACGGCGCTGGCCCCGCTGCGCGCGGGCCGGGCGGCGGCGGGAGAGGTGCCGGCGTGA	MTRIAVITGSTRPRRRAALVAAWVLEVAERHAGSGDVSFEIVDLADFDLPLLDEPVPAAIGDYANEHTRRWARVIDGFDGFVFVTPEYNHSYPAALKNAIDYLFAEWGDKAAGFVSYGLHGGIRAVEHLRAAVSEVKLADVRSCVALSLFADFKITDMTQPGEFAPGDHQEPTLTRMIDEVVAWSTALAPLRAGRAAAGEVPA	MASMRVLVVEDERFMAEAIRDGLRLEAIAADIAGDGDTALDLLGVNAYDIAVLDRDIPGPSGDEIAQRIVASGGGIPILMLTAADRMDDKASGFELGADDYLTKPFELQELVLRLRALDRRRAHSRPPVREIAGLQLDPFRREVYRDGRYVALTRKQFAVLEVLVAAEGGVISAEELLERAWDENADPFTNAVRITVSTLRKRLGEPWLIATVPGVGYRIDTEPDARGGGDGG	87.12	gnl|BL_ORD_ID|4742|hsp_num:0	1689			81	189	vancomycin
BGC0000203.1|BE-7585A_35 # 34488 # 35936 # 1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=GGGAGA;rbs_spacer=9bp;gc_cont=0.743	BGC0000203.1|BE-7585A_35 	34488	35936	+	Loose	900	149.058	lmrB	25.39	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACCCGCGCGGACGCGCCCGCCGCGCCGGCCACGGGTGACCGCATCGGCTGGCCGGTCTGGCGGCTCGCGCTGGTCATCGTGTTCGGGGCGTTCGCGTCCGGGCTCGACGCTTCGCTGACCAACATCGGCCTGGACACCATCGGCGCCGACCTGCACGCCGGGCTCGCCGAGGTGCAGTGGGTCGCGACCGCCTACATCGTCGCGCTCGCCGTTTCGCTGCCGCTGTGCGGCTGGCTGGGCCGCCGGCTCGGCCCGGGGCGGCTCTGGCTGATGGCCCTGGTGGCCTTCACCATCGCCTCCGGGCTGTGCGCGGCCGCGCCCGACGTCGGCTGGCTCATCGCCCTGCGCGTCGTCCAGGGCCTGGCCGCGGGCCTGATGGTCCCGGCGGGCCAGACGATCATCGGCCAGGCGGTCGGCGCCGCGCGGCTGGGCCGGGTGATGTCGACGCTCGGCATCGCCGCGGCGCTGGCCCCGACGCTCGGCCCGGTGGTCGGCGGCCTGGTGCTGCACGCGCTGTCGTGGGAGTGGCTGTTCCTGATCAACCTGCCCATCGGCGCGATCGGCCTGCTGCTCGGCCTCCGCTACGTCCCCCGCGGCGAACGCGGCGGCGCGGCCCCGCTCGACTGGTGGGGTTTCGTGTGGATCGGCGGCGGGCTCCCGCTGCTGGTGTACGCGCTGACGGCGTGGAGTTCGGCGGGCACGATGGCCGCCTGGCCGGTGCTCGCGCCGCTCGTGCTCGGCGTCGCGGGCCTGACGGTGTTCGTCCTGCGCACCCGGCGCCGGGCGAACCCGCTGATGGACCTCGGGCTCTACCGGCGCCCGGTGTACGTCGCGGCCAGCGGCGCGGCCGTGTTCAGCGGCGCCCTGATGTTCGGCGCGGCCCTGGTTTTCCCGCTGTACTTCGAAATCCTGCACCACGACGGCGTGATCGGCACCGGCCTGCGGATGCTCGCGCTCGGCATCGGCACGGCGGTCGCGCTGCCGCTCACCGGCCGGCTGACCGACCGCTACGGCGGCGGCCTGGTCGCGACGTGGGGCAGCGTGGCCGCGCTCGCGACGACGATCGCGTTCCTCTTCGTCGGCGCCGACGCGAACGCCGACCCGGTGCTCATCGAGGTCCTGCTGGTGCTGCTCGGCGCGTCGGTCGCGGCGACCGCGGTCCCGCCCGGGATCGCGGCCTACCAGACGGTGCACCCGGACCAGCTCCCCGACGCCACCACGCAGGTGAACATCGTCCAGCGCATCGGCGGCGCCCTCGGCGGCTCGCTGTACACGGTCACCATCGCCAACGGTCTCGAGGCAGGCGAAGAGCACGCGTTCCGCGGGGTGTTCTGGTGGCTGACCGGCTCGGCCGTGCTCGCGTTGATCTGTTCGCAATGGCTCCGCATCACCCTCCACCGCGCCCGCACCACCCGTGAACCGCTGGAAAGGACGGACGAACAGTGA	MTRADAPAAPATGDRIGWPVWRLALVIVFGAFASGLDASLTNIGLDTIGADLHAGLAEVQWVATAYIVALAVSLPLCGWLGRRLGPGRLWLMALVAFTIASGLCAAAPDVGWLIALRVVQGLAAGLMVPAGQTIIGQAVGAARLGRVMSTLGIAAALAPTLGPVVGGLVLHALSWEWLFLINLPIGAIGLLLGLRYVPRGERGGAAPLDWWGFVWIGGGLPLLVYALTAWSSAGTMAAWPVLAPLVLGVAGLTVFVLRTRRRANPLMDLGLYRRPVYVAASGAAVFSGALMFGAALVFPLYFEILHHDGVIGTGLRMLALGIGTAVALPLTGRLTDRYGGGLVATWGSVAALATTIAFLFVGADANADPVLIEVLLVLLGASVAATAVPPGIAAYQTVHPDQLPDATTQVNIVQRIGGALGGSLYTVTIANGLEAGEEHAFRGVFWWLTGSAVLALICSQWLRITLHRARTTREPLERTDEQ	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	101.05	gnl|BL_ORD_ID|540|hsp_num:0	592			30	1359	
